Результаты поиска - Geoffrey L. Uy

Отмена результатов
  1. 1
    Targeting the Microenvironment in Acute Myeloid Leukemia

    Targeting the Microenvironment in Acute Myeloid Leukemia по Armin Rashidi, Geoffrey L. Uy

    Опубликовано 2015
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia

    Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia по Daniel Guy, Geoffrey L. Uy

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment

    The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment по Sameem Abedin, Geoffrey L. Uy, Laura C. Michaelis

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022

    Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022 по Gregory W. Roloff, Olatoyosi Odenike, Ashish Bajel, Andrew H. Wei, Nicole Foley, Geoffrey L. Uy

    Опубликовано 2022
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells

    BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells по Pablo Ramírez, Michael P. Rettig, Geoffrey L. Uy, Elena Deych, Matthew Holt, Julie Ritchey, John F. DiPersio

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation

    Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation по Michael Slade, Scott Goldsmith, Rizwan Romee, John F. DiPersio, Erik R. Dubberke, Peter Westervelt, Geoffrey L. Uy, Steven J. Lawrence

    Опубликовано 2016
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity

    The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity по Patrick Fogarty, Shelagh D. Campbell, Robin Abu-Shumays, Brigitte de Saint Phalle, Kristina R. Yu, Geoffrey L. Uy, Michael L. Goldberg, William Sullivan

    Опубликовано 1997
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Fresh or Cryopreserved CD34 + -Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation

    Fresh or Cryopreserved CD34 + -Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplant... по Armin Ghobadi, Mark A. Fiala, Giridharan Ramsingh, Feng Gao, Camille N. Abboud, Keith Stockerl‐Goldstein, Geoffrey L. Uy, Brenda J. Grossman, Peter Westervelt, John F. DiPersio

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia

    T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Tra... по Joan How, Michael Slade, Khoan Vu, John F. DiPersio, Peter Westervelt, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Rizwan Romee

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

    Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 по Bruno Nervi, Pablo Ramírez, Michael P. Rettig, Geoffrey L. Uy, Matthew Holt, Julie Ritchey, Julie L. Prior, David Piwnica‐Worms, Gary Bridger, Timothy J. Ley, John F. DiPersio

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

    A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia по Todd A. Fehniger, Geoffrey L. Uy, Kathryn Trinkaus, Alissa Nelson, Jeffery A Demland, Camille N. Abboud, Amanda F. Cashen, Keith Stockerl‐Goldstein, Peter Westervelt, John F. DiPersio, Ravi Vij

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

    Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome по Iskra Pusic, Jaebok Choi, Mark A. Fiala, Feng Gao, Matthew Holt, Amanda F. Cashen, Ravi Vij, Camille N. Abboud, Keith Stockerl‐Goldstein, Meghan A. Jacoby, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

    Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation по Iskra Pusic, Shi Yuan Jiang, Scott Landua, Geoffrey L. Uy, Michael P. Rettig, Amanda F. Cashen, Peter Westervelt, Ravi Vij, Camille N. Abboud, Keith Stockerl‐Goldstein, Diane S. Sempek, Angela Smith, John F. DiPersio

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

    A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia по Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi, Kyle McFarland, Kathryn Trinkaus, Lindsay Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F. Cashen, Keith Stockerl‐Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

    Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide по Scott Goldsmith, Michael Slade, John F. DiPersio, Peter Westervelt, Steven J. Lawrence, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Erik R. Dubberke, Kathryn Trinkaus, Rizwan Romee

    Опубликовано 2016
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  16. 16
    Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation

    Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation по Jacob P. Smeltzer, Amanda F. Cashen, Qin Zhang, Andrew Homb, Farrokh Dehdashti, Camille N. Abboud, John F. DiPersio, Keith Stockerl‐Goldstein, Geoffrey L. Uy, Ravi Vij, Peter Westervelt, Nancy L. Bartlett, Todd A. Fehniger

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

    Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform по Muneera Al-Hussaini, Michael P. Rettig, Julie Ritchey, Darja Karpova, Geoffrey L. Uy, Linda Eissenberg, Feng Gao, William Eades, Ezio Bonvini, Gurunadh R. Chichili, Paul A. Moore, Syd Johnson, Lynne Collins, John F. DiPersio

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated

    Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well... по Ramzi Abboud, Jesse Keller, Michael Slade, John F. DiPersio, Peter Westervelt, Michael P. Rettig, Stéphanie Meier, Todd A. Fehniger, Camille N. Abboud, Geoffrey L. Uy, Ravi Vij, Kathryn Trinkaus, Mark A. Schroeder, Rizwan Romee

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

    A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia по Geoffrey L. Uy, Michael P. Rettig, Richard M. Stone, Marina Konopleva, Michael Andreeff, Kyle McFarland, William D. Shannon, Theresa Fletcher, Teresa Reineck, William Eades, Keith Stockerl‐Goldstein, Camille N. Abboud, Meagan A. Jacoby, Peter Westervelt, John F. DiPersio

    Опубликовано 2017
    Полный текст Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  20. 20
    Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

    Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers по Jorge E. Cortés, Kenji Tamura, Daniel J. DeAngelo, Johann S. de Bono, David Lorente, Mark D. Minden, Geoffrey L. Uy, Hagop M. Kantarjian, Lisa S. Chen, Varsha Gandhi, Robert Godin, Karen Keating, Kristen McEachern, Karthick Vishwanathan, J. Elizabeth Pease, Emma Dean

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: